今开:0.0 | 昨收:0.69 |
最高:0.0 | 最低:0.0 |
涨停价:0.0 | 跌停价:0.0 |
总市值:3.28355E7 |
vccde2015-12-19 21:14
$Capnia, Inc.(CAPN)$ 美国食品药品管理局(FDA)授予Capnia公司的三叉神经痛治疗药物孤儿药资格。孤儿药一般是指治疗罕见疾病的药物,已认定的孤儿药上市后享有7年的市场独占权。查看全文
$Capnia, Inc.(CAPN)$ DEFM14A - Definitive proxy statement relating to merger or acquisition Filed: 2017-02-10 AccNo: 0001193125-17-038579 Size: 4 MB 网页链接
$Capnia, Inc.(CAPN)$ PRER14A - Preliminary Proxy Soliciting materials Filed: 2017-02-09 AccNo: 0001193125-17-036199 Size: 4 MB 网页链接
$Capnia, Inc.(CAPN)$ D - Notice of Exempt Offering of Securities Filed: 2017-02-08 AccNo: 0001484565-17-000001 Size: 11 KB 网页链接
$Capnia, Inc.(CAPN)$ S-1 - General form for registration of securities under the Securities Act of 1933 Filed: 2017-02-01 AccNo: 0001193125-17-027623 Size: 8 MB 网页链接
$Capnia, Inc.(CAPN)$ PRER14A - Preliminary Proxy Soliciting materials Filed: 2017-01-31 AccNo: 0001193125-17-025793 Size: 4 MB 网页链接
$Capnia, Inc.(CAPN)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2017-01-17 AccNo: 0001193125-17-011074 Size: 7 MB 网页链接
$Capnia, Inc.(CAPN)$ 8-K - Current report Filed: 2017-01-09 AccNo: 0001193125-17-004767 Size: 7 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Capnia, Inc.(CAPN)$ PREM14A - Preliminary proxy statements relating to merger or acquisition Filed: 2017-01-05 AccNo: 0001193125-17-003097 Size: 3 MB 网页链接
$Capnia, Inc.(CAPN)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2017-01-03 AccNo: 0001193125-17-000881 Size: 37 KB 网页链接
$Capnia, Inc.(CAPN)$ 8-K - Current report Filed: 2017-01-03 AccNo: 0001193125-17-000880 Size: 37 KBItem 7.01: Regulation FD DisclosureItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接